Form D · Biotechnology
ACCORD BIOMATERIALS INC
Ann Arbor, MI · CIK 0001433520
Offering snapshot reported Oct 20, 2010 · SEC filing
- Reported sold
- $1.2M Offering amount: $1.2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 6, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 20, 2010 | Initial | $1,200,000 | No comparison | 4 | SEC filing |
| Apr 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149361
Source: Form D, filed Oct 20, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kristyn Aalto | Executive |
| Brian Duncan | Director |
| Jan Garfinkle | Director |
| Jeffrey P. Gold | Director |
| Scott Merz | Director |
| John Santini | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3550 W Liberty Suite 3
Ann Arbor, MI, 48103
Ann Arbor, MI, 48103